Combined Host‐Derived and Microbiological Biomarkers for the Detection of Peri‐Implant Bone Loss: A Diagnostic Accuracy Study
- 20 October 2026
- journal article
- research article
- Published by Wiley in Clinical Oral Implants Research
Abstract
Aim: To evaluate the diagnostic accuracy of host‐derived and microbiological biomarkers, alone and in combination with clinical parameters, for the detection of peri‐implant bone loss (BL). Methods: A university‐based cohort of subjects with dental implants was examined at baseline and after a mean follow‐up of 3.9 years. Peri‐implant BL served as the reference standard, defined as > 1 mm between baseline and follow‐up radiographs; implants with < 0.5 mm BL served as controls. At follow‐up, peri‐implant crevicular fluid and submarginal‐microbiological samples were collected. Bone metabolism and inflammatory biomarkers were quantified using Luminex technology. Bacterial loads were quantified by qPCR. Associations of biomarkers with BL were evaluated using multilevel logistic regression models. Diagnostic accuracy was assessed using ROC curves, with AUC, sensitivity, specificity, and predictive values reported. Results: Seventy‐one subjects with 273 implants were included. Twenty‐eight exhibited peri‐implant‐BL > 1.0 mm over the follow‐up period. Increased levels of IL‐1β, T. denticola, Fusobacterium spp., and T. forsythia were associated with BL in unadjusted analyses. However, these associations were no longer statistically significant after adjustment for clinical parameters. Individual biomarkers demonstrated limited diagnostic accuracy (maximum AUC = 0.68). In contrast, biomarker combinations with clinical parameters exhibited excellent discriminative performance (AUC > 0.95). The combination of IL‐1β and BoP‐or‐PPD achieved the highest accuracy (AUC = 0.97). Conclusions: While individual biomarkers showed limited diagnostic utility, combining multiple predictors significantly improved the ability to detect peri‐implant BL. Combining IL‐1β with either BoP or PPD significantly outperformed individual clinical measures but did not outperform the combination of clinical parameters, highlighting the potential of integrated biomarker and clinical parameter approaches as screening tools for detecting BL.Keywords
This publication has 44 references indexed in Scilit:
- Evaluating the role of inflammatory biomarkers as a diagnostic tool in peri-implantitisJournal of Oral Biology and Craniofacial Research, 2025
- Oral Fluid Biomarkers for Peri-Implantitis: A Scoping ReviewInternational Dental Journal, 2023
- Clinical findings and history of bone loss at implant sitesClinical Oral Implants Research, 2020
- Diagnosis of peri‐implantitis in the absence of baseline data: A diagnostic accuracy studyClinical Oral Implants Research, 2020
- Prevalence and risk/protective indicators of peri‐implant diseases: A university‐representative cross‐sectional studyClinical Oral Implants Research, 2020
- Clinical signs, symptoms, perceptions, and impact on quality of life in patients suffering from peri‐implant diseases: a university‐representative cross‐sectional studyClinical Oral Implants Research, 2020
- A systematic review of the microbiota composition in various peri-implant conditions: data from 16S rRNA gene sequencingArchives of Oral Biology, 2020
- IL-1β strengthens the physical barrier in gingival epithelial cellsTissue Barriers, 2020
- Validation of a multiplex qPCR assay for detection and quantification of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythia in subgingival plaque samples. A comparison with anaerobic cultureArchives of Oral Biology, 2019
- Protein biomarkers and microbial profiles in peri‐implantitisClinical Oral Implants Research, 2015